GlassScriptPhysician profile
Alfred R Johnson
NPI 1255343133
$2,299.55
in general payments reported to CMS, 2019-2025
21 companies · $171 in 2025
The $171 reported for 2025 was less than what a typical Allergy & Immunology (Internal Medicine) provider received nationally (typical 2025 total: $681).
See the full distribution for Allergy & Immunology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $708 · 2020: $141 · 2021: $333 · 2022: $479 · 2023: $267 · 2024: $200 · 2025: $171.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $539 · Consulting Fee: $99.19.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $539.07 |
| Consulting Fee | $99.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $615.40 | 2019-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $324.86 | 2020-2025 | Takhzyro, Cuvitru |
| Csl Behring | $211.52 | 2019-2024 | Hizentra, Privigen |
| Grifols USA, LLC | $152.09 | 2020-2023 | Xembify |
| Adma Biomanufacturing LLC | $125.27 | 2022-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $121.81 | 2019 | |
| Mdd US Operations, LLC | $119.47 | 2019 | |
| Shire North American Group INC | $94.25 | 2019 | |
| Novo Nordisk INC | $78.83 | 2022-2025 | Rybelsus, Ozempic, Wegovy |
| Mayne Pharma Commercial LLC | $76.09 | 2019 | |
| Octapharma USA, INC. | $63.03 | 2021 | |
| Pfizer INC. | $61.92 | 2024-2025 | |
| Phadia US INC. | $40.60 | 2023-2024 | Immunocap |
| Blueprint Medicines Corporation | $38.14 | 2022-2023 | Ayvakit |
| Hospira, INC. | $36.19 | 2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alk-Abello, INC | $35.33 | 2019-2020 | |
| Exact Sciences Corporation | $34.20 | 2024-2025 | Cologuard Collection Kit |
| Corcept Therapeutics | $24.89 | 2025 | Korlym |
| Nestle Healthcare Nutrition INC. | $18.68 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.15 | 2019 | |
| Arbor Pharmaceuticals, INC. | $10.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alfred Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.